I would say a few on here have read almost all the historical trials and research papers on Bisantrene. Everything points in the right direction. The only thing that is needed is clinical data / validation. P1 will provide this as part of dose escalation. That is why it’s going to be critical either way. If it’s not Cardio protective in P1 it won’t suddenly be protective in P2 or P3.
Good news is Bisantrene cardioprotective in-vitro and in-vivo (mouse model), which has good translation to ppl for cardiac issues.
p.s. Bisantrene is a modified heart friendly version of Doxorubicin.
- Forums
- ASX - By Stock
- Cardioprotection thread
I would say a few on here have read almost all the historical...
- There are more pages in this discussion • 192 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.41 |
Change
-0.055(3.77%) |
Mkt cap ! $236.2M |
Open | High | Low | Value | Volume |
$1.45 | $1.45 | $1.40 | $157.9K | 111.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3980 | $1.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.41 | 2613 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3980 | 1.400 |
1 | 3440 | 1.395 |
1 | 2500 | 1.380 |
2 | 1100 | 1.360 |
1 | 1534 | 1.350 |
Price($) | Vol. | No. |
---|---|---|
1.410 | 2613 | 2 |
1.440 | 24 | 1 |
1.445 | 319 | 2 |
1.450 | 699 | 2 |
1.455 | 24 | 1 |
Last trade - 16.10pm 28/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.40 |
  |
Change
-0.055 ( 2.23 %) |
|||
Open | High | Low | Volume | ||
$1.44 | $1.44 | $1.40 | 6146 | ||
Last updated 15.46pm 28/05/2024 ? |
Featured News
RAC (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online